The Goldman Sachs Group Lowers Beauty Health (NASDAQ:SKIN) Price Target To $22.00


The Goldman Sachs Group Lowers Beauty Health

Beauty Health's (NASDAQ:SKIN - Get Rating) price target was cut by Goldman Sachs Group equity researchers from $25 to $22 in a report released Tuesday, Marketbeat.com reported. The company currently has a Buy recommendation on the stock. Goldman Sachs Group's price target indicates upside potential of 65.04% from the company's previous close.

Many other brokerages have also rated SKIN. Canaccord Genuity Group cut its price target for Beauty Health from $22 to $20 in a research report released Thursday, June 30. DA Davidson raised its price target for Beauty Health from $24 to $25 and gave the stock a Buy recommendation in a research report on Wednesday, August 10. Canaccord Genuity Group cut its price target for Beauty Health from $22 to $20 and set a Buy rating in a research note on Thursday, June 30. Finally, Piper Sandler cut its price target for Beauty Health from $22 to $20 and gave the stock an overweight rating in a research note on Wednesday, August 10. One analyst rated the stock a Hold and nine a Buy. The company currently has an agreed-upon rating of "Average Buy" and an agreed price target of $24.33, according to MarketBeat.

beauty health price performance

Shares of NASDAQ SKIN opened on Tuesday at $13.33. The company has a debt to equity ratio of 2.08, a quick ratio of 10.59 and a current ratio of 11.44. Beauty Health has a fifty-two week minimum of $9.94 and a fifty-two week maximum of $30.17. The company has a market capitalization of $1.99 billion, a PE of -6.91, and a beta of 1.40. The stock's 50-day simple moving average is $13.12 and the stock's 200-day simple moving average is $14.33.

Institutional inflows and outflows Hedge funds and other institutional investors have recently moved their holdings into equities. SG Americas Securities LLC increased its stake in Beauty Health by 589.7% in the first quarter. SG Americas Securities LLC now owns 36,290 shares of the company worth $613,000 after purchasing an additional 31,028 shares during the last quarter. Bfsg LLC acquired a new position in Beauty Health stock in the first quarter worth approximately $878,000. Centiva Capital LP acquired a new stake in Beauty Health during the fourth quarter for about $2,557,000. Skylands Capital LLC acquired a new stake in Beauty Health for about $471,000 in the first quarter. Finally, Citigroup Inc. increased its stake in Beauty Health by 29.2% in the fourth quarter. Citigroup Inc. now owns 126,307 shares of the company worth $3,053,000 after purchasing an additional 28,523 shares in the most recent quarter. Currently, 72.01% of the shares are owned by hedge funds and other institutional investors. Beauty and health business profile.

(To get Mark)

Beauty Health designs, develops, manufactures, markets and sells beauty products and technologies worldwide. The company's flagship products include the skin-enhancing HydraFacial, which cleanses, exfoliates, exfoliates, extracts, nourishes and hydrates the skin with special solutions and serums.

See also:

Health & Beauty Analyst Recommendations (NASDAQ: SKIN)

Receive beauty and health news and ratings daily - enter your email address below. to get a quick daily summary of the latest news and ratings from Beauty Health analysts and related companies with the FREE Daily MarketBeat.com Newsletter.

MVL. October Seasonality - SCTR Report

Post a Comment (0)
Previous Post Next Post